Ribociclib Succinate
Preliminary reference disclaimer
This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.
Preliminary safety reference
Available
Supplier-issued SDS
Available by request
COA
Available by RFQ / lot confirmation
Transport classification
Requires shipment review
CAS Number
1374639-75-4
Chemical name
Ribociclib Succinate
Molecular formula
C27H36N8O5
Molecular weight
552.6 g/mol
Synonyms
LEE-011 succinate; Birociclib; KISQALI FEMARA CO-PACK COMPONENT RIBOCICLIB SUCCINATE; RIBOCICLIB SUCCINATE COMPONENT OF KISQALI FEMARA CO-PACK; LEE011 succinate; 7-Cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide succinate; Ribociclib succinate [USAN]; Kisqali; Ribociclib succinate (USAN); Kisqali (TN); LEE011 succinate?; BIROCICLIB [WHO-DD]
InChIKey
NHANOMFABJQAAH-UHFFFAOYSA-N
PubChem CID
57334219
Signal word
Danger
Catalog reference cue; confirm supplier documentation before use.
Hazard statements
H301, H315, H319, H372, H400
Catalog reference cue; confirm supplier documentation before use.
Physical property reference values are not available in the current MolGraph catalog record.
Shipment review
Shipment details require review before fulfillment.
Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.